Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Dementia rates are rising globally, impacting healthcare systems and society. The care of people with dementia is largely provided by informal caregivers (e.g., family, friends), which can present significant challenges and increase caregivers' burden. New technologies, such as humanoid socially assistive robots, show promise in reducing this burden, as such robots were considered to b...
BACKGROUND: New or worsening cognitive impairment or dementia is common in older adults following an episode of critical illness, and screening post-discharge is recommended for those at increased risk. There is a need for prediction models of post-ICU cognitive impairment to guide delivery of screening and support resources to those in greatest need. We sought to develop and internally validate a...
In neuroscience, phase synchronization (PS) is a crucial mechanism that facilitates information processing and transmission between different brain re...
Alzheimer's disease is the most common cause of dementia in the elderly population (aged 65 years and over), followed by vascular dementia, Lewy body ...
: Caregivers experience high rates of occupational injuries, especially during wheelchair transfers, which often result in back pain and musculoskelet...
The application of deep learning techniques to analyze brain functional magnetic resonance imaging (fMRI) data has led to significant advancements in ...
Alzheimer's disease (AD), a prevalent neurodegenerative disorder, leads to progressive dementia, which impairs decision-making, problem-solving, and c...
OBJECTIVE: Blood DNA methylation (DNAm) alterations have been widely reported in the onset and progression of mild cognitive impairment (MCI) and Alzh...
BACKGROUND: Alzheimer's disease (AD) is strongly associated with slowly progressive hippocampal atrophy. Elucidating the relationships between local m...
OBJECTIVE: To apply machine learning approaches on EEG event-related oscillations (ERO) to discriminate preclinical Alzheimer's disease (AD) from age-...
BACKGROUND: Alzheimer's disease (AD) and vascular dementia (VaD) share overlapping pathophysiological characteristics, yet comparative genetic studies...
Multimodal neuroimaging data, including magnetic resonance imaging (MRI) and positron emission tomography (PET), provides complementary information ab...
OBJECTIVE: Dementia is a significant medical and social issue in most developed countries. Practical tools for predicting the progression of degenerat...
The detection of patients in the cognitive normal (CN), mild cognitive impairment (MCI), and Alzheimer's disease (AD) stages of neurodegeneration is c...
The clinical spectrum of Alzheimer's disease (AD) ranges dynamically from asymptomatic and mild cognitive impairment (MCI) to mild, moderate, or sever...
Machine learning has gained attention in the medical field. Continuous efforts are being made to develop robust models for early prognosis purposes. T...
Alzheimer's disease (AD) refers to a neurological disorder that causes damage to brain cells and results in decreasing cognitive abilities and memory....
BACKGROUND: In addressing elderly healthcare issues, cognitive impairment can cause significant disruptions in daily life and may potentially develop ...
Accurate and early disease detection is crucial for improving patient care, but traditional diagnostic methods often fail to identify diseases in thei...
BACKGROUND: The underdiagnosis of cognitive impairment hinders timely intervention of dementia. Health professionals working in the community play a c...